Correlation Between Evogene and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Evogene and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Purple Biotech, you can compare the effects of market volatilities on Evogene and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Purple Biotech.
Diversification Opportunities for Evogene and Purple Biotech
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Evogene and Purple is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Evogene i.e., Evogene and Purple Biotech go up and down completely randomly.
Pair Corralation between Evogene and Purple Biotech
Assuming the 90 days trading horizon Evogene is expected to under-perform the Purple Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Evogene is 1.72 times less risky than Purple Biotech. The stock trades about -0.35 of its potential returns per unit of risk. The Purple Biotech is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest 3,140 in Purple Biotech on September 1, 2024 and sell it today you would lose (2,460) from holding Purple Biotech or give up 78.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evogene vs. Purple Biotech
Performance |
| Timeline |
| Evogene |
| Purple Biotech |
Evogene and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Purple Biotech
The main advantage of trading using opposite Evogene and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.The idea behind Evogene and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Compugen | Purple Biotech vs. Purple Biotech | Purple Biotech vs. BioLine RX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |